Does DAPAGLIFLOZIN Cause Hyperglycaemia? 270 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 270 reports of Hyperglycaemia have been filed in association with DAPAGLIFLOZIN (QTERN). This represents 1.3% of all adverse event reports for DAPAGLIFLOZIN.
270
Reports of Hyperglycaemia with DAPAGLIFLOZIN
1.3%
of all DAPAGLIFLOZIN reports
11
Deaths
153
Hospitalizations
How Dangerous Is Hyperglycaemia From DAPAGLIFLOZIN?
Of the 270 reports, 11 (4.1%) resulted in death, 153 (56.7%) required hospitalization, and 58 (21.5%) were considered life-threatening.
Is Hyperglycaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DAPAGLIFLOZIN. However, 270 reports have been filed with the FAERS database.
What Other Side Effects Does DAPAGLIFLOZIN Cause?
Death (2,775)
Diabetic ketoacidosis (1,773)
Acute kidney injury (982)
Off label use (891)
Nausea (884)
Dehydration (860)
Vomiting (838)
Dizziness (817)
Ketoacidosis (803)
Fatigue (785)
What Other Drugs Cause Hyperglycaemia?
INSULIN GLARGINE (1,903)
METFORMIN (1,626)
ALPELISIB (1,575)
DEXAMETHASONE (1,169)
PREDNISONE (1,135)
INSULIN LISPRO (743)
PREDNISOLONE (705)
INSULIN ASPART (646)
INSULIN HUMAN (620)
METHYLPREDNISOLONE (604)
Which DAPAGLIFLOZIN Alternatives Have Lower Hyperglycaemia Risk?
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL
DAPAGLIFLOZIN vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN
DAPAGLIFLOZIN vs DAPRODUSTAT
DAPAGLIFLOZIN vs DAPSONE
DAPAGLIFLOZIN vs DAPTOMYCIN